A total of 1,361 hormone receptor positive (estrogen receptor– positive and/or progesterone receptor– positive) breast cancer patients treated with adjuvant TAM monotherapy were genotyped for CYP2D6*3, *4, *5, *10, *41 and duplications. This evidence concerns the gene CYP2D6 and breast carcinoma.